Loading...
Header Logo

Please contact mskhan2@childrensnational.org for any questions. Can't find your name in profiles ? Request a Profile

Keywords
Last Name
Institution

Conry, Joan

TitleProfessor
InstitutionChildrens National Medical Center
DepartmentNeurophysiology, Epilepsy and Neuro-ICU
Address111 Michigan Ave NW
Washington DC 20010
Phone(202) 4762120
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Fridman I, Cordeiro M, Rais-Bahrami K, McDonald NJ, Reese JJ, Massaro AN, Conry JA, Chang T, Soussou W, Tsuchida TN. Evaluation of Dry Sensors for Neonatal EEG Recordings. J Clin Neurophysiol. 2016 Apr; 33(2):149-55. PMID: 26562208; PMCID: PMC4818163 [Available on 04/01/17].
    2. Ng YT, Conry J, Mitchell WG, Buchhalter J, Isojarvi J, Lee D, Drummond R, Chung S. Clobazam is equally safe and efficacious for seizures associated with Lennox-Gastaut syndrome across different age groups: Post hoc analyses of short- and long-term clinical trial results. Epilepsy Behav. 2015 May; 46:221-6. PMID: 25940107.
      View in: PubMed
    3. Rosenfeld W, Conry J, Lagae L, Rozentals G, Yang H, Fain R, Williams B, Kumar D, Zhu J, Laurenza A. Efficacy and safety of perampanel in adolescent patients with drug-resistant partial seizures in three double-blind, placebo-controlled, phase III randomized clinical studies and a combined extension study. Eur J Paediatr Neurol. 2015 Jul; 19(4):435-45. PMID: 25823975.
      View in: PubMed
    4. Conry JA, Ng YT, Kernitsky L, Mitchell WG, Veidemanis R, Drummond R, Isojarvi J, Lee D, Paolicchi JM. Stable dosages of clobazam for Lennox-Gastaut syndrome are associated with sustained drop-seizure and total-seizure improvements over 3 years. Epilepsia. 2014 Apr; 55(4):558-67. PMID: 24580023; PMCID: PMC4303987.
    5. Salpekar JA, Berl MM, Havens K, Cushner-Weinstein S, Conry JA, Pearl PL, Yaun AL, Gaillard WD. Psychiatric symptoms in children prior to epilepsy surgery differ according to suspected seizure focus. Epilepsia. 2013 Jun; 54(6):1074-82. PMID: 23662984.
      View in: PubMed
    6. Ng YT, Conry J, Paolicchi J, Kernitsky L, Mitchell W, Drummond R, Isojarvi J, Lee D, Owen R. Long-term safety and efficacy of clobazam for Lennox-Gastaut syndrome: interim results of an open-label extension study. Epilepsy Behav. 2012 Dec; 25(4):687-94. PMID: 23141144.
      View in: PubMed
    7. Duke ES, Tesfaye M, Berl MM, Walker JE, Ritzl EK, Fasano RE, Conry JA, Pearl PL, Sato S, Theodore WH, Gaillard WD. The effect of seizure focus on regional language processing areas. Epilepsia. 2012 Jun; 53(6):1044-50. PMID: 22554135; PMCID: PMC3370082.
    8. Pearl PL, Drillings IM, Conry JA. Herbs in epilepsy: evidence for efficacy, toxicity, and interactions. Semin Pediatr Neurol. 2011 Sep; 18(3):203-8. PMID: 22062945.
      View in: PubMed
    9. Terry GE, Conry JA, Taranto E, Yaun A. Failure of a vagus nerve stimulator following a nearby lightning strike. Pediatr Neurosurg. 2011; 47(1):72-3. PMID: 21546762.
      View in: PubMed
    10. Freilich ER, Jones JM, Gaillard WD, Conry JA, Tsuchida TN, Reyes C, Dib-Hajj S, Waxman SG, Meisler MH, Pearl PL. Novel SCN1A mutation in a proband with malignant migrating partial seizures of infancy. Arch Neurol. 2011 May; 68(5):665-71. PMID: 21555645; PMCID: PMC3092158.
    11. Wheless JW, Conry J, Krauss G, Mann A, LoPresti A, Narurkar M. Safety and tolerability of rufinamide in children with epilepsy: a pooled analysis of 7 clinical studies. J Child Neurol. 2009 Dec; 24(12):1520-5. PMID: 19955344.
      View in: PubMed
    12. Conry JA, Ng YT, Paolicchi JM, Kernitsky L, Mitchell WG, Ritter FJ, Collins SD, Tracy K, Kormany WN, Abdulnabi R, Riley B, Stolle J. Clobazam in the treatment of Lennox-Gastaut syndrome. Epilepsia. 2009 May; 50(5):1158-66. PMID: 19170737.
      View in: PubMed
    13. Wheless JW, Carmant L, Bebin M, Conry JA, Chiron C, Elterman RD, Frost M, Paolicchi JM, Donald Shields W, Thiele EA, Zupanc ML, Collins SD. Magnetic resonance imaging abnormalities associated with vigabatrin in patients with epilepsy. Epilepsia. 2009 Feb; 50(2):195-205. PMID: 19054414.
      View in: PubMed
    14. Pearl PL, Vezina LG, Saneto RP, McCarter R, Molloy-Wells E, Heffron A, Trzcinski S, McClintock WM, Conry JA, Elling NJ, Goodkin HP, de Menezes MS, Ferri R, Gilles E, Kadom N, Gaillard WD. Cerebral MRI abnormalities associated with vigabatrin therapy. Epilepsia. 2009 Feb; 50(2):184-94. PMID: 18783433.
      View in: PubMed
    15. Pearl PL, Conry JA, Yaun A, Taylor JL, Heffron AM, Sigman M, Tsuchida TN, Elling NJ, Bruce DA, Gaillard WD. Misidentification of vagus nerve stimulator for intravenous access and other major adverse events. Pediatr Neurol. 2008 Apr; 38(4):248-51. PMID: 18358402.
      View in: PubMed
    16. Shinnar S, Pellock JM, Conry JA. Open-label, long-term safety study of zonisamide administered to children and adolescents with epilepsy. Eur J Paediatr Neurol. 2009 Jan; 13(1):3-9. PMID: 18343174.
      View in: PubMed
    17. Vossler DG, Conry JA, Murphy JV. Zonisamide for the treatment of myoclonic seizures in progressive myoclonic epilepsy: an open-label study. Epileptic Disord. 2008 Mar; 10(1):31-4. PMID: 18367429.
      View in: PubMed
    18. Fountain NB, Conry JA, Rodríguez-Leyva I, Gutierrez-Moctezuma J, Salas E, Coupez R, Stockis A, Lu ZS. Prospective assessment of levetiracetam pharmacokinetics during dose escalation in 4- to 12-year-old children with partial-onset seizures on concomitant carbamazepine or valproate. Epilepsy Res. 2007 Apr; 74(1):60-9. PMID: 17270398.
      View in: PubMed
    19. Cushner-Weinstein S, Berl M, Salpekar JA, Johnson JL, Pearl PL, Conry JA, Kolodgie M, Scully A, Gaillard WD, Weinstein SL. The benefits of a camp designed for children with epilepsy: evaluating adaptive behaviors over 3 years. Epilepsy Behav. 2007 Feb; 10(1):170-8. PMID: 17145202.
      View in: PubMed
    20. Salpekar JA, Conry JA, Doss W, Cushner-Weinstein S, Pearl PL, Weinstein SL, Gaillard WD. Clinical experience with anticonvulsant medication in pediatric epilepsy and comorbid bipolar spectrum disorder. Epilepsy Behav. 2006 Sep; 9(2):327-34. PMID: 16861047.
      View in: PubMed
    21. Pearl PL, Robbins EL, Bennett HD, Conry JA. Use of complementary and alternative therapies in epilepsy: cause for concern. Arch Neurol. 2005 Sep; 62(9):1472-5. PMID: 16157759.
      View in: PubMed
    22. Conry JA. Pharmacologic treatment of the catastrophic epilepsies. Epilepsia. 2004; 45 Suppl 5:12-6. PMID: 15283706.
      View in: PubMed
    23. Weinstein SL, Conry J. New antiepileptic drugs: comparative studies of efficacy and cognition. Curr Neurol Neurosci Rep. 2002 Mar; 2(2):134-41. PMID: 11898480.
      View in: PubMed
    24. Conry JA. Progressive myoclonic epilepsies. J Child Neurol. 2002 Jan; 17 Suppl 1:S80-4. PMID: 11918469.
      View in: PubMed
    Conry's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _